SlideShare uma empresa Scribd logo
1 de 36
The Lean LaunchPad

Lecture 2: Value Proposition

           Steve Blank
            Jon Feiber
            Jon Burke
           Jerry Engel

          #leanlaunchpad
VALUE PROPOSITIONS




  what are you offering them?
   what is that getting done
    for them? do they care?
                          images by JAM
Value                                                Customer
                                                Proposition                                            Segments
                                                                           Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                           (Image Atlas)
Radiology              and drugs                                                                       Radiopharmacies
                                                Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies   Purity                                                 Equipment producers
                       Develop regulatory       Speed
                       plan for pre IND         PET/SPECT                                              Prescribing physicians
cGMP manufacturers                              Multiplatform                Technical assistance
Radiopharmacies        meeting
                       ID cGMP CRO              Sensitivity (nca)                                      Radiologist who
                       Fund-raising             Specific compounds                                     perform studies


                                                        General
 Pharmaceutical        IP                           methodology for        Direct sales of precursor
 development           PoP data                    adding fluorine to                                    Drug developers
 companies                                        lead compounds of         Sales of packaged
                        IP                              interest            precursor in cassettes
                        PoP data
                                                                                                        Radiologists
                        Regulatory plan                                    Cassette manufacturers
                        Understanding of
                        the regulatory
                        process



                                                              Sales of intermediates
   Contract cGMP precursor manufacture
   Salary, Rents
                                                              Technology license
   Clinical trials
                                                              Product license (royalty)
Value                                                 Customer
                                                Proposition                                             Segments
                                                                           Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                           (Image Atlas)
Radiology              and drugs                                                                       Radiopharmacies
                                                Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies   Purity                                                 Equipment producers
                       Develop regulatory       Speed
                       plan for pre IND         PET/SPECT                                              Prescribing physicians
cGMP manufacturers
Radiopharmacies        meeting
                       ID cGMP CRO
                                                          Product/Market Fit
                                                Multiplatform
                                                Sensitivity (nca)
                                                Specific compounds
                                                                             Technical assistance
                                                                                                       Radiologist who
                       Fund-raising                                                                    perform studies


                                                        General
 Pharmaceutical        IP                           methodology for        Direct sales of precursor
 development           PoP data                    adding fluorine to                                    Drug developers
 companies                                        lead compounds of         Sales of packaged
                        IP                              interest            precursor in cassettes
                        PoP data
                                                                                                        Radiologists
                        Regulatory plan                                    Cassette manufacturers
                        Understanding of
                        the regulatory
                        process



                                                              Sales of intermediates
   Contract cGMP precursor manufacture
   Salary, Rents
                                                              Technology license
   Clinical trials
                                                              Product license (royalty)
Get, Keep
                                                                            and Grow
                                                                           Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                           (Image Atlas)
Radiology              and drugs                                                                       Radiopharmacies
                                                Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies   Purity                                                 Equipment producers
                       Develop regulatory       Speed
                                                PET/SPECT
cGMP manufacturers
Radiopharmacies
                       plan for pre IND
                       meeting                  Multiplatform                Technical assistance      Customer
                                                                                                       Prescribing physicians

                       ID cGMP CRO              Sensitivity (nca)                                      Radiologist who
                       Fund-raising             Specific compounds                                     Segments
                                                                                                       perform studies


                                                        General
                                                                              Channel
 Pharmaceutical        IP                           methodology for        Direct sales of precursor
 development           PoP data                    adding fluorine to
                                                                                                         Drug developers
 companies                                        lead compounds of
                                                                            Sales of packaged
                        IP                              interest
                                                                            precursor in cassettes
                        PoP data
                                                                                                        Radiologists
                        Regulatory plan
                        Understanding of                                   Cassette manufacturers
                        the regulatory
                        process



                                                              Sales of intermediates
   Contract cGMP precursor manufacture
   Salary, Rents
                                                              Technology license
   Clinical trials
                                                              Product license (royalty)
Get, Keep
                                                                            and Grow
                                                                           Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                           (Image Atlas)
Radiology              and drugs                                                                       Radiopharmacies
                                                Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies   Purity                                                 Equipment producers
                       Develop regulatory       Speed
                                                PET/SPECT

 Who Are Our Customers?
cGMP manufacturers
Radiopharmacies
                       plan for pre IND
                       meeting                  Multiplatform                Technical assistance      Customer
                                                                                                       Prescribing physicians

                       ID cGMP CRO              Sensitivity (nca)                                      Radiologist who
                       Fund-raising             Specific compounds                                     Segments
                                                                                                       perform studies
 How Do We Reach Them?                                                        Channel
                                                        General
 Pharmaceutical        IP                           methodology for        Direct sales of precursor
 development           PoP data                    adding fluorine to
                                                                                                         Drug developers
 companies                                        lead compounds of
                                                                            Sales of packaged
                        IP                              interest
                                                                            precursor in cassettes
                        PoP data
                                                                                                        Radiologists
                        Regulatory plan
                        Understanding of                                   Cassette manufacturers
                        the regulatory
                        process



                                                              Sales of intermediates
   Contract cGMP precursor manufacture
   Salary, Rents
                                                              Technology license
   Clinical trials
                                                              Product license (royalty)
Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                            (Image Atlas)
Radiology              and drugs                                                                        Radiopharmacies
                                                 Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies    Purity                                                 Equipment producers
                       Develop regulatory        Speed
                       plan for pre IND          PET/SPECT                                              Prescribing physicians
cGMP manufacturers                               Multiplatform                Technical assistance
Radiopharmacies        meeting
                       ID cGMP CRO               Sensitivity (nca)                                      Radiologist who
                       Fund-raising              Specific compounds                                     perform studies


                                                         General
 Pharmaceutical        IP                            methodology for        Direct sales of precursor
 development           PoP data                     adding fluorine to
                                                                                                          Drug developers
 companies                                         lead compounds of
                                                                             Sales of packaged
                        IP                               interest
                                                                             precursor in cassettes
                        PoP data
                                                                                                         Radiologists
                        Regulatory plan
                        Understanding of                                    Cassette manufacturers
                        the regulatory
                        process




   Contract cGMP precursor manufacture
                                                Costs          Sales of intermediates                   Revenue
   Salary, Rents
                                                               Technology license
   Clinical trials
                                                               Product license (royalty)
Technical Assistance
Nuclear Medicine and   SOPs for precursors
                                                                            (Image Atlas)
Radiology              and drugs                                                                        Radiopharmacies
                                                 Accessibility (RCY)        FDA regulatory support
departments            Recruit clinical sites
                       In vivo animal studies    Purity                                                 Equipment producers
                       Develop regulatory        Speed
                       plan for pre IND          PET/SPECT                                              Prescribing physicians
cGMP manufacturers                               Multiplatform                Technical assistance
Radiopharmacies        meeting
                       ID cGMP CRO               Sensitivity (nca)                                      Radiologist who
                       Fund-raising              Specific compounds                                     perform studies


                                                         General
 Pharmaceutical        IP                            methodology for        Direct sales of precursor
 development           PoP data                     adding fluorine to
                                                                                                          Drug developers
 companies                                         lead compounds of
                         How Do We Make Money?
                        IP
                        PoP data
                                                         interest
                                                                             Sales of packaged
                                                                             precursor in cassettes
                                                                                                         Radiologists
                        Regulatory plan
                        Understanding of                                    Cassette manufacturers
                        the regulatory
                        process




   Contract cGMP precursor manufacture
                                                Costs          Sales of intermediates                   Revenue
   Salary, Rents
                                                               Technology license
   Clinical trials
                                                               Product license (royalty)
Where we are…
Key Questions for Value Prop

• Problem Statement: What is the problem?
• Ecosystem: For whom is this relevant?
• Competition: What do customers do today?
• Technology / Market Insight: Why is the problem so
  hard to solve?
• Market Size: How big is this problem?
• Product: How do you do it?
Step 1. Spec. the Value Proposition
• Product(s)?
• Service(s)?
• Ecosystem?

• Is it a company or just a product?
Problem Statement


• What is the problem?

• How do you justify your existence?
Value Proposition – Common Mistake

•   Is it just a feature of someone else’s product
•   Is it a “nice to have” product
•   Is it a “got to have” product
•   Can it scale to a company?
Value Proposition - Discovery
• Product
  – Long term vision
  – features
  – Benefits
  – Minimum Viable Product spec
• For a web/mobile app
  – Low fidelity MVP live and running
• Understand Customer Problem and Solution
• Test Market Type
Product

• Problem Statement: What is the problem?
• Technology / Market Insight: Why is the problem so hard to
  solve?
• Market Size: How big is this problem?
• Competition: What do customers do today?
• Product: How do you do it?
Step 2: What’s the Minimum Viable Product –
                   Physical

 • First, test your understanding of the problem
 • Next test your understanding of the solution
    – Proves that it solves a core problem for customers
    – The minimum set of features needed to learn from earlyvangelists
 - Interviews, demos, prototypes, etc
 - Lots of eyeball contact
Step 2: What’s the Minimum Viable Product –
                 Web/Mobile

 • NOW “low fidelity” web/app for customer feedback
    – First, tests your understanding of the problem
 • LATER, “high fidelity” web/app tests your understanding of
   the solution
    – Proves that it solves a core problem for customers
    – The minimum set of features needed to learn from earlyvangelists
 - Avoid building products nobody wants
 - Maximize the learning per time spent
Key Questions for Value Prop

• Problem Statement: What is the problem?
• Ecosystem: For whom is this relevant?
• Competition: What do customers do today?
• Technology / Market Insight: Why is the problem so
  hard to solve?
• Market Size: How big is this problem?
• Product: How do you do it?
Market Type
Type of Market Changes Everything


    Existing   Resegmented    New     Clone
    Market        Market     Market   Market
Type of Market
             Changes Everything
      Existing      Resegmented       New             Clone
      Market           Market        Market           Market


• Market            • Sales              •Customers
  – Market Size        –   Sales Model
                                          •Customers
                                            • Needs
  – Cost of Entry                              • Needs
                       –   Margins            • Adoption
  – Launch Type        –   Sales Cycle
                                               • Adoption
  – Competitive        –   Chasm Width    •Finance
    Barriers                               •Finance Capital
                                             • Ongoing
  – Positioning                                 • Ongoing Capital
                                               • Time to Profitability
                                                • Time to Profitability
Definitions: Four Types of Markets
         Existing     Resegmented         New        Clone
         Market          Market          Market      Market

• Existing Market
   – Faster/Better = High end
• Resegmented Market
   – Niche = marketing/branding driven
   – Cheaper = low end
• New Market
   – Cheaper/good enough can create a new class of
     product/customer
   – Innovative/never existed before
• Clone Market
      • Local adapatation
Market Type
                 Existing       Resegmented           New           Clone
Customers     Known           Possibly Known     Unknown         Possibly
                                                                 Known
Customer      Performance     Better fit         Transform-      Local version
Needs                                            ational
                                                 improvement
Competitors   Many            Many if wrong,     None            None
                              few if right
Risk          Lack of         Market and         Evangelism      Misjudge
              branding, sales product re-        and education   local needs
              and             definition         cycle
              distribution
              ecosystem
Examples      Google           Southwest
                          Market Type determines:  Groupon       Baidu
                          Rate of customer adoption
                        Sales and Marketing strategies
                              Cash requirements
Market Type - Existing
• Incumbents exist, customers can name the mkt
• Customers want/need better performance
• Usually technology driven

• Positioning driven by product and how much value customers
  place on its features

• Risks:
   – Incumbents will defend their turf
   – Network effects of incumbent
   – Continuing innovation
Market Type – Resementing Existing
• Low cost provider (Southwest)
• Unique niche via positioning (Whole Foods)

• What factors can:
   –   you eliminate that your industry has long competed on?
   –   Be reduced well below the industry’s standard?
   –   should be raised well above the industry’s standard?
   –   be created that the industry has never offered? (blue ocean)
Market Type – New
•   Customers don’t exist today
•   How will they find out about you?
•   How will they become aware of their need?
•   How do you know the market size is compelling?

• Which factors should be created that the industry has never
  offered? (blue ocean)
Market Type – Clone
• Takes foreign business model and adapts it to local conditions
   –   Language
   –   Culture
   –   Import restrictions
   –   Local control/ownership
• Need market large enough >100 million
Competition

• What are customers doing today?
• Are competitors threatening to offer
  better price or value?
• How saturated is our market?
Technology and Market Insight
     Technology Insight         Market Insight
•   Moore’s Law             Value chain disruption
•   New scientific          Deregulation
    discoveries             Changes in how
•   Typically applies to     people work, live and
    hardware, clean          interact and what they
    techand biotech          expect
Examples of Market Insight
          • People want to play more involved
            games than what is currently offered
          • Facebook can be the distribution for
            such games

           Masses of people are more likely to micro-
            blog than blog
           The non-symmetric relationships will allow
            companies and individuals to self-promote
            and will impact distribution

           European car sharing sensibilities could be
            adopted in North America
           People, particularly in urban
            environments, no longer wanted to own
            cars but wanted to have flexibility.
Examples of Technical Insight
               • Topological analysis enables
                 highly dimensional data to be
                 analyzed without
                 predetermining number of
                 feature sets



                Mass produced components
                 can be used to create a
                 miniaturized fluorescence
                 microscope
Types of Product Value

   Comes from Technical Insight           Comes from Market Insight


          More Efficient
                                  Lower          Better
                                   cost                          Better
Smaller                                       Distribution
                                                                Bundling


                              Simpler
      Faster

                                                  Better
                                                 Branding
How do I test value proposition
         hypotheses?
Define Product
•   Hardware
•   Service
•   Knowledge
•   Resources
•   Networks
•   Data
Minimum Viable Product (MVP)

          • A product that solves a core
            problem for customers

          • The minimum set of features
            needed to learn from
            earlyvangelists
             - Avoid building products nobody
               wants
             - Maximize the learning per dollar
               spent
The Art of the MVP

• A MVP is not a minimal product
• “But my customers don’t know what they want!”
• At what point of “I don’t get it!” will I declare defeat?

Mais conteúdo relacionado

Mais procurados

Effective Agile Retrospectives
Effective Agile RetrospectivesEffective Agile Retrospectives
Effective Agile Retrospectives
Yuval Yeret
 
Business Model Design
Business Model DesignBusiness Model Design
Business Model Design
Yves Pigneur
 

Mais procurados (20)

041310 class 12 and 13
041310 class 12 and 13041310 class 12 and 13
041310 class 12 and 13
 
Creating awesome value proposition using Value Proposition Canvas
Creating awesome value proposition using Value Proposition CanvasCreating awesome value proposition using Value Proposition Canvas
Creating awesome value proposition using Value Proposition Canvas
 
Effective Agile Retrospectives
Effective Agile RetrospectivesEffective Agile Retrospectives
Effective Agile Retrospectives
 
Business Model Canvas
Business Model CanvasBusiness Model Canvas
Business Model Canvas
 
How to Start An Innovation Program
How to Start An Innovation ProgramHow to Start An Innovation Program
How to Start An Innovation Program
 
Innovation Games™
Innovation Games™Innovation Games™
Innovation Games™
 
Lean Startup 101
Lean Startup 101Lean Startup 101
Lean Startup 101
 
Customer Development Class 1 And 2 090409
Customer Development Class 1 And 2 090409Customer Development Class 1 And 2 090409
Customer Development Class 1 And 2 090409
 
Business Model Design
Business Model DesignBusiness Model Design
Business Model Design
 
Techniques for Effective Retrospectives
Techniques for Effective RetrospectivesTechniques for Effective Retrospectives
Techniques for Effective Retrospectives
 
Testing Your MVP
Testing Your MVPTesting Your MVP
Testing Your MVP
 
Introduction to Customer Development at the Lean Startup Intensive at Web 2.0...
Introduction to Customer Development at the Lean Startup Intensive at Web 2.0...Introduction to Customer Development at the Lean Startup Intensive at Web 2.0...
Introduction to Customer Development at the Lean Startup Intensive at Web 2.0...
 
Find the Job-to-be-Done. Pains, gains, needs, and wants
Find the Job-to-be-Done. Pains, gains, needs, and wantsFind the Job-to-be-Done. Pains, gains, needs, and wants
Find the Job-to-be-Done. Pains, gains, needs, and wants
 
Successful entrepreneurship 1
Successful entrepreneurship 1Successful entrepreneurship 1
Successful entrepreneurship 1
 
An Intro to Lean Startup
An Intro to Lean StartupAn Intro to Lean Startup
An Intro to Lean Startup
 
Innovation accounting and key metrics for startups
Innovation accounting and key metrics for startupsInnovation accounting and key metrics for startups
Innovation accounting and key metrics for startups
 
Customer Discovery Skills
Customer Discovery Skills Customer Discovery Skills
Customer Discovery Skills
 
Product Strategy
Product StrategyProduct Strategy
Product Strategy
 
Y Combinator Startup Class #2 : Ideas, Products, Teams and Execution
Y Combinator Startup Class #2 : Ideas, Products, Teams and ExecutionY Combinator Startup Class #2 : Ideas, Products, Teams and Execution
Y Combinator Startup Class #2 : Ideas, Products, Teams and Execution
 
Lean product development
Lean product developmentLean product development
Lean product development
 

Semelhante a Lecture 2 NSF I-Corps March 2012 value prop

Startupweekendintroduction 120224152312-phpapp01
Startupweekendintroduction 120224152312-phpapp01Startupweekendintroduction 120224152312-phpapp01
Startupweekendintroduction 120224152312-phpapp01
quantrong92
 
Ground flour pharma final presentation
Ground flour pharma final presentationGround flour pharma final presentation
Ground flour pharma final presentation
Stanford University
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
finance40
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
finance40
 
Benno Oderkerk - Avantes
Benno Oderkerk - AvantesBenno Oderkerk - Avantes
Benno Oderkerk - Avantes
Themadagen
 
Company Presentation
Company PresentationCompany Presentation
Company Presentation
sleitgeb
 
Pistoia presentation bio it-worldexpo 21april2010
Pistoia presentation   bio it-worldexpo 21april2010Pistoia presentation   bio it-worldexpo 21april2010
Pistoia presentation bio it-worldexpo 21april2010
Nick Lynch
 

Semelhante a Lecture 2 NSF I-Corps March 2012 value prop (20)

Startup weekend introduction
Startup weekend introductionStartup weekend introduction
Startup weekend introduction
 
Startupweekendintroduction 120224152312-phpapp01
Startupweekendintroduction 120224152312-phpapp01Startupweekendintroduction 120224152312-phpapp01
Startupweekendintroduction 120224152312-phpapp01
 
Ground flour pharma final presentation
Ground flour pharma final presentationGround flour pharma final presentation
Ground flour pharma final presentation
 
Sen severe final presentation
Sen severe final presentationSen severe final presentation
Sen severe final presentation
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
 
MEDfx Connected Healthcare V6 20101014
MEDfx Connected Healthcare V6 20101014MEDfx Connected Healthcare V6 20101014
MEDfx Connected Healthcare V6 20101014
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
 
cGMP Aspects of Design
cGMP Aspects of DesigncGMP Aspects of Design
cGMP Aspects of Design
 
Benno Oderkerk - Avantes
Benno Oderkerk - AvantesBenno Oderkerk - Avantes
Benno Oderkerk - Avantes
 
Company Presentation
Company PresentationCompany Presentation
Company Presentation
 
Automation: a key role for Molecular Diagnostic Evolution
Automation: a key role for Molecular Diagnostic EvolutionAutomation: a key role for Molecular Diagnostic Evolution
Automation: a key role for Molecular Diagnostic Evolution
 
Medical Imaging Seminar Company Presentations
Medical Imaging Seminar Company PresentationsMedical Imaging Seminar Company Presentations
Medical Imaging Seminar Company Presentations
 
Pistoia presentation bio it-worldexpo 21april2010
Pistoia presentation   bio it-worldexpo 21april2010Pistoia presentation   bio it-worldexpo 21april2010
Pistoia presentation bio it-worldexpo 21april2010
 
Pharma protocol manufacturing
Pharma protocol   manufacturingPharma protocol   manufacturing
Pharma protocol manufacturing
 
CTC Union introduction 2012
CTC Union introduction 2012CTC Union introduction 2012
CTC Union introduction 2012
 
The Expanding eClinical Universe: Streamlining Progress by Changing Current W...
The Expanding eClinical Universe: Streamlining Progress by Changing Current W...The Expanding eClinical Universe: Streamlining Progress by Changing Current W...
The Expanding eClinical Universe: Streamlining Progress by Changing Current W...
 
Anchovi NSF final Presentation
Anchovi  NSF final PresentationAnchovi  NSF final Presentation
Anchovi NSF final Presentation
 
Biz model for ion proton dna sequencer
Biz model for ion proton dna sequencerBiz model for ion proton dna sequencer
Biz model for ion proton dna sequencer
 
Lab Informatics 09 Se
Lab Informatics 09 SeLab Informatics 09 Se
Lab Informatics 09 Se
 

Mais de Stanford University

Mais de Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Último

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Último (20)

Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

Lecture 2 NSF I-Corps March 2012 value prop

  • 1. The Lean LaunchPad Lecture 2: Value Proposition Steve Blank Jon Feiber Jon Burke Jerry Engel #leanlaunchpad
  • 2. VALUE PROPOSITIONS what are you offering them? what is that getting done for them? do they care? images by JAM
  • 3. Value Customer Proposition Segments Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed plan for pre IND PET/SPECT Prescribing physicians cGMP manufacturers Multiplatform Technical assistance Radiopharmacies meeting ID cGMP CRO Sensitivity (nca) Radiologist who Fund-raising Specific compounds perform studies General Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of Sales of packaged IP interest precursor in cassettes PoP data Radiologists Regulatory plan Cassette manufacturers Understanding of the regulatory process Sales of intermediates Contract cGMP precursor manufacture Salary, Rents Technology license Clinical trials Product license (royalty)
  • 4. Value Customer Proposition Segments Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed plan for pre IND PET/SPECT Prescribing physicians cGMP manufacturers Radiopharmacies meeting ID cGMP CRO Product/Market Fit Multiplatform Sensitivity (nca) Specific compounds Technical assistance Radiologist who Fund-raising perform studies General Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of Sales of packaged IP interest precursor in cassettes PoP data Radiologists Regulatory plan Cassette manufacturers Understanding of the regulatory process Sales of intermediates Contract cGMP precursor manufacture Salary, Rents Technology license Clinical trials Product license (royalty)
  • 5. Get, Keep and Grow Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed PET/SPECT cGMP manufacturers Radiopharmacies plan for pre IND meeting Multiplatform Technical assistance Customer Prescribing physicians ID cGMP CRO Sensitivity (nca) Radiologist who Fund-raising Specific compounds Segments perform studies General Channel Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of Sales of packaged IP interest precursor in cassettes PoP data Radiologists Regulatory plan Understanding of Cassette manufacturers the regulatory process Sales of intermediates Contract cGMP precursor manufacture Salary, Rents Technology license Clinical trials Product license (royalty)
  • 6. Get, Keep and Grow Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed PET/SPECT Who Are Our Customers? cGMP manufacturers Radiopharmacies plan for pre IND meeting Multiplatform Technical assistance Customer Prescribing physicians ID cGMP CRO Sensitivity (nca) Radiologist who Fund-raising Specific compounds Segments perform studies How Do We Reach Them? Channel General Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of Sales of packaged IP interest precursor in cassettes PoP data Radiologists Regulatory plan Understanding of Cassette manufacturers the regulatory process Sales of intermediates Contract cGMP precursor manufacture Salary, Rents Technology license Clinical trials Product license (royalty)
  • 7. Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed plan for pre IND PET/SPECT Prescribing physicians cGMP manufacturers Multiplatform Technical assistance Radiopharmacies meeting ID cGMP CRO Sensitivity (nca) Radiologist who Fund-raising Specific compounds perform studies General Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of Sales of packaged IP interest precursor in cassettes PoP data Radiologists Regulatory plan Understanding of Cassette manufacturers the regulatory process Contract cGMP precursor manufacture Costs Sales of intermediates Revenue Salary, Rents Technology license Clinical trials Product license (royalty)
  • 8. Technical Assistance Nuclear Medicine and SOPs for precursors (Image Atlas) Radiology and drugs Radiopharmacies Accessibility (RCY) FDA regulatory support departments Recruit clinical sites In vivo animal studies Purity Equipment producers Develop regulatory Speed plan for pre IND PET/SPECT Prescribing physicians cGMP manufacturers Multiplatform Technical assistance Radiopharmacies meeting ID cGMP CRO Sensitivity (nca) Radiologist who Fund-raising Specific compounds perform studies General Pharmaceutical IP methodology for Direct sales of precursor development PoP data adding fluorine to Drug developers companies lead compounds of How Do We Make Money? IP PoP data interest Sales of packaged precursor in cassettes Radiologists Regulatory plan Understanding of Cassette manufacturers the regulatory process Contract cGMP precursor manufacture Costs Sales of intermediates Revenue Salary, Rents Technology license Clinical trials Product license (royalty)
  • 10. Key Questions for Value Prop • Problem Statement: What is the problem? • Ecosystem: For whom is this relevant? • Competition: What do customers do today? • Technology / Market Insight: Why is the problem so hard to solve? • Market Size: How big is this problem? • Product: How do you do it?
  • 11. Step 1. Spec. the Value Proposition • Product(s)? • Service(s)? • Ecosystem? • Is it a company or just a product?
  • 12. Problem Statement • What is the problem? • How do you justify your existence?
  • 13. Value Proposition – Common Mistake • Is it just a feature of someone else’s product • Is it a “nice to have” product • Is it a “got to have” product • Can it scale to a company?
  • 14. Value Proposition - Discovery • Product – Long term vision – features – Benefits – Minimum Viable Product spec • For a web/mobile app – Low fidelity MVP live and running • Understand Customer Problem and Solution • Test Market Type
  • 15. Product • Problem Statement: What is the problem? • Technology / Market Insight: Why is the problem so hard to solve? • Market Size: How big is this problem? • Competition: What do customers do today? • Product: How do you do it?
  • 16. Step 2: What’s the Minimum Viable Product – Physical • First, test your understanding of the problem • Next test your understanding of the solution – Proves that it solves a core problem for customers – The minimum set of features needed to learn from earlyvangelists - Interviews, demos, prototypes, etc - Lots of eyeball contact
  • 17. Step 2: What’s the Minimum Viable Product – Web/Mobile • NOW “low fidelity” web/app for customer feedback – First, tests your understanding of the problem • LATER, “high fidelity” web/app tests your understanding of the solution – Proves that it solves a core problem for customers – The minimum set of features needed to learn from earlyvangelists - Avoid building products nobody wants - Maximize the learning per time spent
  • 18. Key Questions for Value Prop • Problem Statement: What is the problem? • Ecosystem: For whom is this relevant? • Competition: What do customers do today? • Technology / Market Insight: Why is the problem so hard to solve? • Market Size: How big is this problem? • Product: How do you do it?
  • 20. Type of Market Changes Everything Existing Resegmented New Clone Market Market Market Market
  • 21. Type of Market Changes Everything Existing Resegmented New Clone Market Market Market Market • Market • Sales •Customers – Market Size – Sales Model •Customers • Needs – Cost of Entry • Needs – Margins • Adoption – Launch Type – Sales Cycle • Adoption – Competitive – Chasm Width •Finance Barriers •Finance Capital • Ongoing – Positioning • Ongoing Capital • Time to Profitability • Time to Profitability
  • 22. Definitions: Four Types of Markets Existing Resegmented New Clone Market Market Market Market • Existing Market – Faster/Better = High end • Resegmented Market – Niche = marketing/branding driven – Cheaper = low end • New Market – Cheaper/good enough can create a new class of product/customer – Innovative/never existed before • Clone Market • Local adapatation
  • 23. Market Type Existing Resegmented New Clone Customers Known Possibly Known Unknown Possibly Known Customer Performance Better fit Transform- Local version Needs ational improvement Competitors Many Many if wrong, None None few if right Risk Lack of Market and Evangelism Misjudge branding, sales product re- and education local needs and definition cycle distribution ecosystem Examples Google Southwest Market Type determines: Groupon Baidu  Rate of customer adoption  Sales and Marketing strategies  Cash requirements
  • 24. Market Type - Existing • Incumbents exist, customers can name the mkt • Customers want/need better performance • Usually technology driven • Positioning driven by product and how much value customers place on its features • Risks: – Incumbents will defend their turf – Network effects of incumbent – Continuing innovation
  • 25. Market Type – Resementing Existing • Low cost provider (Southwest) • Unique niche via positioning (Whole Foods) • What factors can: – you eliminate that your industry has long competed on? – Be reduced well below the industry’s standard? – should be raised well above the industry’s standard? – be created that the industry has never offered? (blue ocean)
  • 26. Market Type – New • Customers don’t exist today • How will they find out about you? • How will they become aware of their need? • How do you know the market size is compelling? • Which factors should be created that the industry has never offered? (blue ocean)
  • 27. Market Type – Clone • Takes foreign business model and adapts it to local conditions – Language – Culture – Import restrictions – Local control/ownership • Need market large enough >100 million
  • 28. Competition • What are customers doing today? • Are competitors threatening to offer better price or value? • How saturated is our market?
  • 29. Technology and Market Insight Technology Insight Market Insight • Moore’s Law  Value chain disruption • New scientific  Deregulation discoveries  Changes in how • Typically applies to people work, live and hardware, clean interact and what they techand biotech expect
  • 30. Examples of Market Insight • People want to play more involved games than what is currently offered • Facebook can be the distribution for such games  Masses of people are more likely to micro- blog than blog  The non-symmetric relationships will allow companies and individuals to self-promote and will impact distribution  European car sharing sensibilities could be adopted in North America  People, particularly in urban environments, no longer wanted to own cars but wanted to have flexibility.
  • 31. Examples of Technical Insight • Topological analysis enables highly dimensional data to be analyzed without predetermining number of feature sets  Mass produced components can be used to create a miniaturized fluorescence microscope
  • 32. Types of Product Value Comes from Technical Insight Comes from Market Insight More Efficient Lower Better cost Better Smaller Distribution Bundling Simpler Faster Better Branding
  • 33. How do I test value proposition hypotheses?
  • 34. Define Product • Hardware • Service • Knowledge • Resources • Networks • Data
  • 35. Minimum Viable Product (MVP) • A product that solves a core problem for customers • The minimum set of features needed to learn from earlyvangelists - Avoid building products nobody wants - Maximize the learning per dollar spent
  • 36. The Art of the MVP • A MVP is not a minimal product • “But my customers don’t know what they want!” • At what point of “I don’t get it!” will I declare defeat?

Notas do Editor

  1. Try it out with a few teams – toy team – what is the problem? What if you were to explain this to your users? What about your customers? What about a education blogger? Decision maker and economic buyer are the sameParkpoint Capital – government, payment processors, who else?Oral light – suppliers, channels (schein), contract manufacturer, etc.Use board to map out these different parts of the ecosystem – we will deep dive in the next 2 slides.WHO IS THE AUDIENCE? Is it an investor? Is it a customer? Is it a user?
  2. What alternative does the customer have right now? How aware are they of the problem?Important context for value proposition – how new is this idea? – Market type
  3. Market insight is becoming more and more a requirement
  4. Generally impacts some part of your business model diagram (usually NOT the product component)
  5. Generally a product / value proposition question
  6. Others: Brand/Status, easier to access (distribution); fun; bundling (phone + camera) faster, simpler, smaller, lower cost, more efficient
  7. First – how would you define product? (go through different teams)